Associations among depression, antidepressants, survival and quality of life in hematopoietic cell transplant recipients
Bone Marrow Transplant
.
2020 Sep;55(9):1868-1871.
doi: 10.1038/s41409-020-0937-y.
Epub 2020 May 12.
Authors
Anna Barata
1
2
,
Brian D Gonzalez
2
,
Jun-Min Zhou
3
,
Jongphil Kim
3
,
Aasha I Hoogland
2
,
Areej El-Jawahri
4
,
Margaret Booth-Jones
2
,
Heather S L Jim
5
Affiliations
1
II-B & José Carreras Leukemia Research Institute, Barcelona, Spain.
2
Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA.
3
Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
4
Department of Hematology/Oncology Massachusetts General Hospital, Boston, MA, USA.
5
Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA. Heather.Jim@moffitt.org.
PMID:
32398786
PMCID:
PMC7968382
DOI:
10.1038/s41409-020-0937-y
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Antidepressive Agents
Depression
Hematopoietic Stem Cell Transplantation*
Humans
Quality of Life
Transplant Recipients*
Substances
Antidepressive Agents
Grants and funding
P30 CA076292/CA/NCI NIH HHS/United States